Edit |   |
---|---|
Product Name | SARS-CoV-2 (COVID-19) NSP8 Protein |
Description | NSP8, forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers. To ultimately combat the emerging COVID-19 pandemic, it is desired to develop an effective and safe vaccine against this highly contagious disease caused by the SARS-CoV-2 coronavirus. By investigating the entire proteome of SARS-CoV-2, six Proteins, including the S Protein and five non-structural Proteins (nsp3, 3CL-pro, and nsp8-10) were predicted to be adhesins, which are crucial to the viral adhering and host invasion. The S, nsp3, and nsp8 Proteins were also predicted by Vaxign-ML to induce high protective Antigenicity. Purity 95.00%. MW: 23.9 kDa |
Size | 100 ug, 1 mg |
Concentration | n/a |
Applications | n/a |
Other Names | NSP8,nsp8,Non-structural protein 8 |
Gene, Accession, CAS # | NCBI: YP_009725304.1 |
Catalog # | orb640164 |
Price | $663 |
Order / More Info | SARS-CoV-2 (COVID-19) NSP8 Protein from BIORBYT LTD. |
Product Specific References | n/a |
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558